Malignant blood diseases in the elderly
Poisson, J.; Chaoui, D.
Soins. Gerontologie 112: 16-19
2015
ISSN/ISBN: 1268-6034 PMID: 25966520 Document Number: 684475
Hematological malignancies are more frequent in elderly patients. Treatment efficacy has been improved during the last decade. Long term remission can be achieved.The challenge is to identify elderly patients illegible for a curative treatment.This highlights the role of geriatric involvement in the management of patients with hematological malignancies.
Document emailed within 1 workday
Related Documents
Koubek, K.; Herzog, P.; Libánsky, J. 1980: Separation of blood cells from normal blood and blood of patients with various malignant blood diseases using separation media Folia Haematologica 107(1): 41-53Kekomäki, R. 1989: Stability of blood cell preparations for malignant blood diseases Duodecim; Laaketieteellinen Aikakauskirja 105(11): 1138-1147
Ellegaard, J.; Nielsen, J.L. 1999: Angiogenesis in malignant blood diseases Ugeskrift for Laeger 161(26): 4012
Fedorova, O.I.; Kondurtsev, V.A.; Davydkin, I.L.; Limareva, L.V. 2008: Peripheral blood responses in elderly patients with some prevalent diseases Klinicheskaia Meditsina 86(2): 48-51
Nurmukhamedov, R.M. 1973: Coagulating activity of blood in certain surgical diseases in the elderly patients Khirurgiia 49(8): 81-85
Gorin, N.C.; Tessier, F.; Najman, A.; Duhamel, G.; Andre, R. 1975: Infections during malignant blood diseases. Value of the carbenicillin-gentamicin combination La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 51(28): 1927-1933
Schauenstein, E.; Kronberger, L.; Schaur, R.J.; Fink, E.; Georgiopulos, E. 1973: Malate and oxaloacetate levels in whole blood of patients with and without malignant tumor diseases Wiener Klinische Wochenschrift 85(26): 478-482
Bussel, A.; Danon, F.; Ferchal, F.; Pérol, Y. 1978: Cytomegalovirus infection in malignant blood diseases:clinical and laboratory data in 29 patients Nouvelle Revue Francaise d'Hematologie 20(1): 67-76
Hokland, P.; Ommen, H.Beier.; Nyvold, C.Guldborg.; Stentoft, J.; Braendstrup, K.; Andersen, B.Lind.; Mikkelsen, L.Siig.; Ostergaard, M. 2009: Minimal residual disease in malignant diseases of the blood II. Translation and therapeutic consequences Ugeskrift for Laeger 171(4): 232-235
Gonzales, R.; Auclair, C.; Voisin, E.; Gautero, H.; Dhermy, D.; Boivin, P. 1984: Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant diseases Cancer Research 44(9): 4137-4139
Kauf, E.; Fuchs, D.; Winnefeld, K.; Hermann, J.; Zintl, F. 1997: Blood selenium content after conditioning and during the course of bone marrow transplantation in children with malignant diseases Medizinische Klinik 92(Suppl 3): 46-47
Chen, Y.X. 1990: Expression of interleukin 2(IL-2) receptor and proliferative response to rIL-2 of peripheral blood mononuclear cells (PBMC) in patients with malignant diseases Zhonghua Zhong Liu Za Zhi 12(4): 281-283
Ueyoshi, A.; Kiura, Y.; Ota, K.; Okamoto, Y. 1988: The discrepancy on measurement of parathyroid hormone in blood under the condition of diseases in hemodialysis patients with renal insufficiency and elderly osteoporotic patients Ryumachi 28(5): 324-333
Duhamel, G.; Stachowiak, J.; Deloux, J.; Lecomte, D.; de St Maur, P.; Najman, A.; Gorin, N. 1981: Acute leukaemias with myelofibrosis. Clinical, cytohistological and evolutive aspects. their place among malignant blood diseases with myelofibrosis La Nouvelle Presse Medicale 10(14): 1119-1123
Kobayashi, N.; Akiya, M. 1980: Bedside conference in pediatric nursing. 10. The nursing of children with respiratory diseases (No. 3), neurologic diseases (No. 2), malignant neoplasms (No. 3), hematologic diseases (No. 5) and kidney Kango Tenbo. Japanese Journal of Nursing Science 5(10): 922-933
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Amery, A.; Birkenhäger, W.; Brixko, P.; Bulpitt, C.; Clement, D.; Deruyttere, M.; De Schaepdryver, A.; Fagard, R.; Forette, F.; Forte, J. 1986: Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE) Postgraduate Medical Journal 62(732): 919-924
Reshad, K.; Suzuki, K.; Inui, K.; Takahashi, Y.; Umemiya, M.; Nakano, Y.; Sakamoto, M.; Takeuchi, Y.; Shimada, T. 1985: The sensitivity and specificity of tumor markers (CEA, ferritin, beta 2-MG, TPA, IAP, sialic acid) in malignant and non-malignant pulmonary diseases and their relation to smoking and sex Nihon Kyobu Shikkan Gakkai Zasshi 23(11): 1343-1350
Vose, B.M.; Moore, M.; Schofield, P.F.; Dymock, I.W. 1975: Leucocytotoxicity in malignant and non-malignant colonic diseases Clinical and Experimental Immunology 22(3): 393-398
Alli, C.; Avanzini, F.; Bettelli, G.; Colombo, F.; Corso, R.; Di Tullio, M.; Marchioli, R.; Mariotti, G.; Radice, M.; Taioli, E. 1992: Prevalence and variability of orthostatic hypotension in the elderly. Results of the 'Italian study on blood pressure in the elderly (SPAA)'. The 'Gruppo di Studio Sulla Pressione Arteriosa nell'Anziano' European Heart Journal 13(2): 178-182